These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37070)

  • 21. Barbiturates and aortic and venous smooth-muscle function.
    Altura BT; Altura BM
    Anesthesiology; 1975 Oct; 43(4):432-44. PubMed ID: 1180401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the anticonvulsant properties of l-propylhexedrine, phenobarbital and a salt-like complex of l-propylhexedrine and phenobarbital in mice and rats.
    Dick RW; Mitchell CL
    Arch Int Pharmacodyn Ther; 1967 Dec; 170(2):333-42. PubMed ID: 6076581
    [No Abstract]   [Full Text] [Related]  

  • 23. A comparison of the discriminative stimulus effects of ethanol, barbital, and phenobarbital in rats.
    York JL
    Psychopharmacology (Berl); 1978 Dec; 60(1):19-23. PubMed ID: 104341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the anticonvulsant, neurotoxic and lethal effects of diphenylbarbituric acid, phenobarbital and diphenylhydantoin in the mouse.
    Raines A; Niner JM; Pace DG
    J Pharmacol Exp Ther; 1973 Aug; 186(2):315-22. PubMed ID: 4719784
    [No Abstract]   [Full Text] [Related]  

  • 25. The prolonging effect of N,N'-diallylpentobarbital on the drug-induced sleep and motor incoordination.
    Yamamoto I; Tateoka Y; Watanabe K; Nabeshima T; Fontenot HJ; Ho IK
    Res Commun Chem Pathol Pharmacol; 1985 Nov; 50(2):209-19. PubMed ID: 4081315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of topiramate on the anticonvulsant activity of conventional antiepileptic drugs in two models of experimental epilepsy.
    Borowicz KK; Luszczki JJ; Duda AM; Czuczwar SJ
    Epilepsia; 2003 May; 44(5):640-6. PubMed ID: 12752462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physical dependence to barbital compared to pentobarbital. II. Tolerance characteristics.
    Boisse NR; Okamoto M
    J Pharmacol Exp Ther; 1978 Mar; 204(3):507-13. PubMed ID: 564951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical dependence to barbital compared to pentobarbital. I. "Chronically equivalent" dosing method.
    Boisse NR; Okamoto M
    J Pharmacol Exp Ther; 1978 Mar; 204(3):497-506. PubMed ID: 564950
    [No Abstract]   [Full Text] [Related]  

  • 29. [Studies on the structure-activity relationship of allyl substituted oxopyrimidines searching for the novel antagonist or agonist of barbiturates to the sleep mechanism based on the uridine receptor theory--barbituric acid to uridine (part I)].
    Yamamoto I
    Yakugaku Zasshi; 2005 Jan; 125(1):73-120. PubMed ID: 15635282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Unexpected interactions of some psychotropic drugs with barbital and pentobarbital effects in mice (author's transl)].
    Simon P; Chermat R; Doaré L; Bourin M; Farinotti R
    J Pharmacol; 1982; 13(2):241-52. PubMed ID: 7098486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
    Löscher W; Hönack D
    Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential sensitivity to ethanol, pentobarbital, and barbital in spontaneously hypertensive and normotensive Wistar-Kyoto rats.
    Khanna JM; Lê AD; Kalant H; Kim C
    Psychopharmacology (Berl); 1985; 86(3):296-301. PubMed ID: 3929299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of chronic pentobarbital treatment on the development of cross-tolerance to ethanol and barbital.
    Khanna JM; Lê AD; Gougos A; Kalant H
    Pharmacol Biochem Behav; 1988 Sep; 31(1):179-86. PubMed ID: 3252249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions of cocaine with barbital, pentobarbital and ethanol.
    Misra AL; Pontani RB; Vadlamani NL
    Arch Int Pharmacodyn Ther; 1989; 299():44-54. PubMed ID: 2774771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of 5,5-diphenylbarbituric acid on experimental seizures in rats: correlation between plasma and brain concentrations and anticonvulsant activity.
    Raines A; Baumel I; Gallagher BB; Niner JM
    Epilepsia; 1975 Nov; 16(4):575-81. PubMed ID: 1204594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticonvulsant activity of 2- and 3-aminobenzanilides.
    Clark CR; Lin CM; Sansom RT
    J Med Chem; 1986 Aug; 29(8):1534-7. PubMed ID: 3735320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of chronic delta 9-tetrahydrocannabinol administration on schedule-controlled behavior of pigeons: cross-tolerance to pentobarbital and barbital.
    Chait LD; Brocco MJ; McMillan DE
    Psychopharmacology (Berl); 1981; 75(1):1-4. PubMed ID: 6272342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative anticonvulsant activity and neurotoxicity of felbamate and four prototype antiepileptic drugs in mice and rats.
    Swinyard EA; Sofia RD; Kupferberg HJ
    Epilepsia; 1986; 27(1):27-34. PubMed ID: 3004930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of NMDA antagonists on development of rapid tolerance to various barbiturates.
    Khanna JM; Kalant H; Chau A; Shah G
    Alcohol; 1998 Jan; 15(1):9-18. PubMed ID: 9426832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of ethanol on pentetrazol-induced seizures and anticonvulsant activity of phenobarbital and valproate against maximal electroshock in mice.
    Kleinrok Z; Dziki M; Janczarek T
    Pol J Pharmacol; 1993; 45(4):361-8. PubMed ID: 8118481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.